International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Medicinal Plant Biochemistry Research for Preventing Degenerative Diseases in Asia

Helda Susanti, Poncojari Wahyono, Abdulkadir Rahardjanto

Master of Biology Education, Postgraduate Program, Universitas Muhammadiyah Malang, Indonesia

Article Information

Volume / Issue5 / 4 (October-December 2024)
Pages251-255
AccessOpen Access

Publication Timeline

  • Received31 October 2024
  • Accepted02 December 2024

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Degenerative diseases—including type 2 diabetes, cardiovascular disease, neurodegeneration, and osteoarthritis—are rising rapidly across Asia due to demographic ageing, urbanization, and lifestyle transitions. Medicinal plants are deeply embedded in Asian health systems and cultural practices, creating opportunities for biochemistry research to support prevention through mechanism‑aligned interventions (e.g., metabolic regulation, anti‑inflammatory pathways, endothelial protection, microbiome‑metabolite modulation). However, many plant-based studies remain stuck at early evidence stages (single antioxidant assays or crude extracts), with limited standardization, safety evaluation, and human evidence. This article provides a framework synthesis (≤2024) of medicinal plant biochemistry research for degenerative disease prevention in Asia. We integrate evidence on shared biochemical pathways of degenerative diseases (oxidative stress, chronic inflammation, metabolic dysregulation, proteostasis failure), metabolomics and natural products workflows (Fiehn, 2002; Sumner et al., 2007; Wolfender et al., 2019), natural products’ role in therapeutic discovery (Newman & Cragg, 2020; Atanasov et al., 2021), and governance under the Nagoya Protocol (CBD, 2011; Oberthür & Rosendal, 2014). Results are presented as two conceptual figures (a pathway map and an evidence‑translation ladder) and three implementation tables mapping (1) biochemical targets and assays, (2) evidence ladder and reporting criteria, and (3) challenges with mitigation strategies for higher education institutions. We argue that high-impact prevention research requires moving beyond antioxidant-only screening to multi-target mechanism panels, rigorous metabolite identification, dose–response and bioavailability considerations, contamination control, and staged human biomarker studies. We conclude with an institutional roadmap emphasizing shared analytical cores, reproducible workflows, ethical access and benefit-sharing, and clinical/public health partnerships to generate credible evidence and scalable interventions.

Keywords

Degenerative DiseasesAsiaMedicinal PlantsBiochemistryMetabolomicsNatural ProductsPreventionType 2 DiabetesCardiovascular DiseaseNeurodegenerationInflammationOxidative StressTranslationStandardization

References

  1. Atanasov AG, Zotchev SB, Dirsch VM, International Natural Product Sciences Taskforce. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200-16. [Google Scholar][Crossref]
  2. Convention on Biological Diversity. Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization. 2011. [Google Scholar][Crossref]
  3. Fiehn O. Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1-2):155-71. [Google Scholar][Crossref]
  4. Heinrich M, Jalil B, Potocnik T, et al. Best practice in ethnopharmacology and ethnobotany: a review and recommendations. J Ethnopharmacol. 2020;249:112376. [Google Scholar][Crossref]
  5. Karuppiah K, et al. Impact of circular bioeconomy on industry’s sustainable performance: A systematic literature review. Sustainability. 2023;15(14):10759. [Google Scholar][Crossref]
  6. Mahato DK, et al. Foodomics: a sustainable approach for the specific nutrition and diets for human health. Food Chem X. 2024;24:101872. [Google Scholar][Crossref]
  7. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770-803. [Google Scholar][Crossref]
  8. Oberthür S, Rosendal GK. Global governance of genetic resources: access and benefit sharing after the Nagoya Protocol. London: Routledge; 2014. [Google Scholar][Crossref]
  9. Qin GF, Zhang X, Zhu F, et al. MS/MS-based molecular networking: an efficient approach for natural products dereplication. Molecules. 2023;28(1):157. https://doi.org/10.3390/molecules28010157 [Google Scholar][Crossref]
  10. Rai A, et al. Plant metabolomics: methods and applications. Plant Sci. 2017 [review]. [Google Scholar][Crossref]
  11. Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis. Metabolomics. 2007;3(3):211-21. [Google Scholar][Crossref]
  12. World Health Organization. Quality control methods for herbal materials. Geneva: WHO; 2011. [Google Scholar][Crossref]
  13. Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016;15(7):473-84. [Google Scholar][Crossref]
  14. Wolfender JL, Litaudon M, Touboul D, Queiroz EF. Innovative strategies for natural product dereplication and identification in the metabolomics era. Nat Prod Rep. 2019;36(6):855-68. [Google Scholar][Crossref]
  15. Yousof NSAM, et al. Molecular networking-based mass spectral identification of metabolites in medicinal plants. Fitoterapia. 2024. [Google Scholar][Crossref]
  16. Zhang X, et al. Polyphenols and chronic disease prevention: mechanisms and evidence. 2021. Copyright and License © The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. [Google Scholar][Crossref]

How to Cite

Susanti, H., Wahyono, P., & Rahardjanto, A. (2024). Medicinal Plant Biochemistry Research for Preventing Degenerative Diseases in Asia. International Journal of Medical and All Body Health Research, 5(4), 251-255. https://doi.org/10.54660/IJMBHR.2024.5.4.251-255

Susanti, Helda, et al. "Medicinal Plant Biochemistry Research for Preventing Degenerative Diseases in Asia." International Journal of Medical and All Body Health Research, vol. 5, no. 4, 2024, pp. 251-255. https://doi.org/10.54660/IJMBHR.2024.5.4.251-255.

Susanti, H., Wahyono, P. and Rahardjanto, A. (2024) 'Medicinal Plant Biochemistry Research for Preventing Degenerative Diseases in Asia', International Journal of Medical and All Body Health Research, 5(4), pp. 251-255. doi: 10.54660/IJMBHR.2024.5.4.251-255.

Susanti H, Wahyono P, Rahardjanto A. Medicinal Plant Biochemistry Research for Preventing Degenerative Diseases in Asia. International Journal of Medical and All Body Health Research. 2024;5(4):251-255. doi:10.54660/IJMBHR.2024.5.4.251-255

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.